Details for Patent: 10,385,341
Which drugs does patent 10,385,341 protect, and when does it expire?
Patent 10,385,341 protects QALSODY and is included in one NDA.
This patent has seventy-four patent family members in thirty countries.
Summary for Patent: 10,385,341
| Title: | Compositions for modulating SOD-1 expression |
| Abstract: | Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS). |
| Inventor(s): | Eric E. Swayze |
| Assignee: | Ionis Pharmaceuticals Inc , Biogen MA Inc |
| Application Number: | US15/301,004 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 10,385,341
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | 10,385,341 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,385,341
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3126499 | ⤷ Start Trial | CR 2024 00038 | Denmark | ⤷ Start Trial |
| European Patent Office | 3126499 | ⤷ Start Trial | 301293 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3126499 | ⤷ Start Trial | LUC00359 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 3126499 | ⤷ Start Trial | PA2024531 | Lithuania | ⤷ Start Trial |
| European Patent Office | 3126499 | ⤷ Start Trial | 2024C/538 | Belgium | ⤷ Start Trial |
| European Patent Office | 3126499 | ⤷ Start Trial | 122024000060 | Germany | ⤷ Start Trial |
| European Patent Office | 3126499 | ⤷ Start Trial | 34/2024 | Austria | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
